


Regional innovation funding is becoming more locally directed, with regional leaders expected to play a larger role in shaping how public R&D investment supports jobs, business growth and local economic strengths. For UK businesses, this could change how grant strategies are planned, evidenced and aligned with regional priorities.
For CFOs, CEOs and innovation leads, the message is clear: grant funding is no longer only about having a technically strong project. Businesses increasingly need to show how their innovation fits a wider local economic plan, supports sector clusters and creates credible commercial outcomes.
Regional innovation funding is public support designed to help local areas strengthen research, development and commercialisation activity. It can support projects linked to local sector strengths, skills, infrastructure, technology adoption and business-led innovation.
Unlike national grant competitions that apply the same broad criteria across the UK, regional innovation funding often gives greater weight to local economic priorities. This can include advanced manufacturing in one region, life sciences in another, clean energy in another, or digital infrastructure where local capability already exists.
For businesses, this means funding strategy needs to answer two questions at the same time:
This second question is becoming more important. A strong application may need to show why the project belongs in a specific place, how it uses local assets and how it could support jobs, supply chains or business productivity in that area.
The UK is trying to connect R&D investment more closely to regional economic growth. Giving local and regional leaders more influence over innovation funding is intended to help areas back projects that match their existing strengths and growth plans.
This matters because innovation does not happen evenly across the country. Some regions have strong university research bases but weaker commercialisation routes. Others have deep industrial capability but need more support to adopt new technologies, attract investment or build specialist skills.
A more localised approach could help funding decisions reflect:
For companies, the opportunity is useful but more demanding. A business may need to position its innovation as part of a regional growth story, not simply as an internal R&D project.
UK businesses may need to make grant applications more place-specific. Funders could expect clearer evidence that a project supports regional economic objectives, not only company-level growth.
This does not mean technical quality becomes less important. A weak project will not become fundable because it is locally aligned. However, a technically strong project may perform better if it also shows a clear link to the region’s priorities.
For example, a manufacturer developing automation technology in a region with an advanced manufacturing strategy may need to show how the project supports productivity, supplier resilience or local technical capability. A life sciences company near a university cluster may need to explain how collaboration, clinical validation or local talent will support the route to market.
The strongest applications are likely to combine:
CFOs and CEOs should treat regional innovation funding as part of a broader non-dilutive funding strategy, not as a one-off grant opportunity. The key task is to map business projects against both national funding routes and regional priorities.
For leadership teams, this creates a governance question. Innovation funding decisions should sit close to financial planning, capital allocation and technical roadmapping. A company that waits until a grant opens may struggle to produce the evidence, partnerships and cost model needed in time.
A more resilient approach is to maintain a live funding roadmap. This should identify which projects could fit regional funding, Innovate UK competitions, UKRI-backed opportunities, Horizon Europe calls, R&D tax relief and other forms of innovation finance.
Action |
Why it matters |
| Map your R&D pipeline by region | Helps identify which projects align with local economic priorities |
| Review local sector strategies | Supports stronger evidence of regional fit |
| Build partnerships early | Regional funding often rewards credible collaboration |
| Prepare project costs in advance | Reduces rushed budgeting when competitions open |
| Align grants with R&D tax planning | Helps avoid duplication, weak evidence and fragmented funding decisions |
| Track regional policy updates | Funding priorities can shift as local leaders gain more influence |
Sectors with strong regional clusters are likely to benefit most from localised innovation funding. This includes industries where local supply chains, infrastructure or research assets already support growth.
Likely areas of interest include:
The opportunity will vary by region. A clean energy company in Scotland, a battery supply chain business in the Midlands, a medtech company in Cambridge or a digital infrastructure business in the North West may each need a different funding case.
The common point is that regional context now matters. Businesses should be ready to explain why the location strengthens the project and why the project strengthens the location.
Grant applications may need stronger local economic evidence. Businesses should expect more emphasis on regional partnerships, local job creation, supply chain value and alignment with local innovation strategies.
This changes how applications should be written. Generic claims about growth, innovation or economic impact are unlikely to be enough. A stronger application will show:
This is where many businesses underprepare. They focus heavily on the technology and leave the economic case too broad. A project may be innovative, but funders need to understand why it should receive public funding and why the proposed location is credible.
Regional innovation funding and R&D tax relief can support the same wider innovation strategy, but they are not the same mechanism. Grants usually fund defined future work, while R&D tax relief supports qualifying expenditure on eligible R&D activities.
For CFOs, the challenge is coordination. A business that receives grant funding may need to consider how that grant interacts with R&D tax relief, especially where subsidised expenditure, project funding rules or scheme eligibility are relevant.
Good governance matters because poor coordination can create problems later. Businesses should keep clear records of:
A joined-up approach helps reduce duplication, improves auditability and gives finance teams a clearer view of the company’s total innovation funding position.
Businesses should prepare a regional funding evidence pack before a competition opens. This should include project rationale, technical work packages, regional alignment, partner roles, cost assumptions and expected economic outcomes.
A practical pack might include:
This preparation reduces the risk of rushing an application in the final week. It also helps leadership teams decide which competitions are worth pursuing and which are a poor fit.
Regional innovation funding works best when local execution is connected to a wider commercial strategy. For international businesses, UK regional funding can support local delivery while fitting into broader group-level R&D and investment plans.
This is especially relevant for companies operating across multiple jurisdictions. A business may be running R&D in the UK, manufacturing in Europe, commercialisation in North America and supply chain activity across several markets. Funding decisions need to account for that complexity.
FI Group by EPSA supports businesses with this type of cross-border innovation planning. The value is not only identifying a grant. It is understanding how UK regional funding, national R&D incentives and international support mechanisms fit together without creating unnecessary compliance, reporting or cost-allocation issues.
For CFOs and group executives, this matters because funding strategy must be scalable. A local grant can support a project, but the wider value comes from building a repeatable framework for funding, evidence and delivery across markets.
A good regional funding strategy starts with the business plan, not the grant deadline. It identifies which projects deserve external funding support, which regions are strategically relevant and which evidence is needed before applications open.
Good strategy usually includes:
This approach helps businesses avoid low-probability applications. It also protects internal teams from spending time on competitions that look attractive but do not match the project’s stage, location, sector or funding need.
Regional innovation funding is public funding aimed at supporting R&D, commercialisation and innovation-led growth in specific local areas. It usually focuses on regional strengths, local jobs, business productivity and collaboration between companies, universities, research bodies and public-sector partners.
It matters because more funding decisions may be shaped by local economic priorities. Businesses may need to show how their projects support regional growth, not just company-level innovation. This can affect grant strategy, partnership planning and evidence requirements.
A business can improve its chances by aligning its project with local priorities, preparing a clear commercial case, building credible partnerships and showing why public funding is needed. Strong applications connect technical innovation with measurable regional benefit.
Not always. Some programmes may focus on SMEs, while others may allow larger businesses, universities, research organisations or consortia to participate. Eligibility depends on the specific fund, so businesses should check scheme rules before committing time to an application.
Innovate UK grants are often national competitions with defined technology or policy themes. Regional innovation funding may place more emphasis on local economic strategies, regional clusters and place-based impact. Some opportunities may involve both national bodies and local decision-makers.
In some cases, a business may use both grant funding and R&D tax relief as part of its wider innovation funding strategy. However, the interaction can be complex. Companies should assess how grant-funded expenditure affects R&D tax eligibility and documentation.
Funders usually expect to see a clear project plan, credible costs, technical rationale, market need, delivery capability and evidence of economic impact. For regional funding, they may also expect evidence of local alignment, partner involvement and regional benefit.
No. Businesses should prepare project summaries, cost models, partner evidence and regional alignment statements before competitions open. This improves decision-making and reduces the risk of rushed, weak applications.
A new £14 million UK Germany quantum funding initiative will back joint R&D, photonics and shared standards. For quantum start ups and corporates, this signals fresh bilateral grant opportunities and a need to align R&D tax relief, grant funding and private capital.
The UK and Germany have announced a £14 million package to deepen collaboration in quantum technologies, unveiled during German President Frank Walter Steinmeier’s State Visit to the UK in December 2025.
The announcement has three pillars:
Government analysis suggests quantum could contribute around £11 billion to UK GDP and over 100,000 jobs by 2045, reflecting the scale of the opportunity in quantum computing, sensing and navigation systems.
In short, this initiative is not just symbolic diplomacy. It is a targeted intervention to knit together two of Europe’s strongest quantum ecosystems around joint funding, standards and applied industrial research.
Detailed call guidance has not yet been published, but the press release confirms that a £6 million bilateral quantum R&D call will open in early 2026, with matched contributions from Innovate UK and VDI Germany.
Based on previous UK bilateral programmes, quantum innovators should expect several common design features:
Alongside the call, the £8 million for Fraunhofer’s Glasgow centre is designed to accelerate commercialisation by supporting applied photonics research that underpins many quantum systems, as well as providing UK firms with a high quality industrial R&D partner.
The NPL PTB agreement on quantum standards will help ensure that devices and protocols developed under this initiative are aligned with emerging international metrology frameworks, lowering future interoperability risk for manufacturers.
This announcement sits within a wider UK Germany Strategic Science and Technology Partnership, launched in 2024 under the Kensington Treaty to deepen collaboration in areas including quantum, AI and clean tech.
For quantum specifically:
On the macro side, FI Group’s recent analysis shows that UK R&D spending has fallen by £2.8 billion in real terms since 2021, raising questions about how the UK will sustain its growth ambitions. HMRC’s latest statistics confirm that the number of R&D tax credit claims dropped by 26 per cent in 2023 to 2024, with SME claims down 31 per cent and total support estimated at £7.6 billion.
In that context, this UK Germany quantum funding initiative is significant for three reasons:
For quantum companies that sit at the intersection of capital intensive hardware and long time to revenue, those signals matter.
CFOs in quantum and advanced technologies face a particular set of pressures:
The UK Germany initiative touches all three.
Quantum and deep tech businesses should treat the UK Germany initiative as a catalyst to professionalise their funding strategy rather than as a one off opportunity.
FI Group works with quantum, photonics and advanced computing companies across the UK, Germany and the wider EU to:
In prior publications on UK R&D spending and quantum computing funding, we have highlighted the need to blend national and international grants with tax incentives to offset inflationary pressures and maintain innovation momentum. Companies seeking a deeper dive into UK competition mechanics can draw on funding advisers’ guidance on UK grant competitions and R&D tax services published on our website.
For leadership teams looking to respond pragmatically, a structured approach helps. Over the next 6 to 12 months:
Before final guidance is released, many innovators share similar questions. The answers below summarise what is known so far and how companies can position themselves.
Q1. When will the UK Germany quantum funding call open?
The government announcement states that a £6 million joint quantum R&D funding call from the UK and Germany will launch in early 2026, with Innovate UK and VDI Germany each contributing £3 million. Exact opening and closing dates will be set out in the formal competition briefing notes.
Q2. Who is likely to be eligible to apply?
While detailed eligibility is pending, prior bilateral calls suggest that consortia will include at least one UK and one German organisation. UK applicants are likely to include SMEs, large companies and research organisations eligible under Innovate UK rules, with German partners funded under VDI managed schemes. Academic only projects are unlikely to be prioritised over industry led collaborations.
Q3. Can companies combine this funding with R&D tax relief?
In principle, UK companies can still claim R&D tax relief on eligible expenditure, but the interaction between notified state aid and the merged scheme can be complex. Some costs supported by notifiable grants may need to be excluded or treated under the RDEC style mechanism. CFOs should model scenarios and seek specialist advice to avoid double counting or non compliant claims.
Q4. How does this initiative relate to other quantum grants in the UK and EU?
The bilateral call will sit alongside national instruments such as the UK National Quantum Technologies Programme and specific Innovate UK competitions, as well as European schemes including Horizon Europe and EuroHPC. Companies may be able to run sequential or complementary projects, but duplicating costs across programmes is prohibited.
Q5. What should CFOs and leadership teams do now?
The most productive actions now are partner scouting, project prioritisation and funding strategy design. That includes mapping where bilateral projects fit within your wider quantum roadmap, planning match funding and stress testing cash flow. Being ready with a credible, costed project concept when call details appear will be more valuable than reacting at the last minute.